The C5-Fc molecule is a recombinant fusion protein consisting of two llama-derived single-domain antibodies called C5 and two glycosylated Fc regions of human IgG1 antibodies. This fusion protein is produced in mammalian cells and has demonstrated therapeutic efficacy in a hamster model with SARS-CoV-2 infection.